Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18263277 | LIPID NANOPARTICLE ADJUVANT COMPOSITION FOR PNEUMOCOCCAL CONJUGATE VACCINES | Non-Final OA | Merck Sharp & Dohme LLC |
| 18623087 | CYANOBACTERIAL HOSTS AND METHODS FOR PRODUCING CHEMICALS | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17969740 | COXIELLA BURNETII AVIRULENT NINE MILE PHASE II VIABLE BACTERIA AND METHODS OF USE | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17637028 | APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN RESPIRATORY DISEASE | Final Rejection | Sichuan University |
| 17794744 | INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST | Non-Final OA | DANISCO US INC. |
| 17763354 | IMMUNOGENIC COMPOSITIONS | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy